≥ 140mg/dL< 60y.o.GailmodelTyrer-CuzickmodelstatinTimedup andgo test≥ 200mg/dL40-59 y.o.,ASCVD ≥10%, lowbleeding risk6.5%q1ymammogramwomenage 55-64 y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsanxietyherpeszostercervicalcancerraloxifenecardiovasculardiseasearomataseinhibitors40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factorq1-2ymammogrambased on lifeexpectancy /health statusdyslipidemiaPREVENTequationq2y2 doses,2-6monthsapartHIVHepatitisCFractureRiskAssessmentToolcolorectalcancertobaccouse40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactors50y.o.q15y≥ 100mg/dLhypertension≥20%insufficientevidenceforscreeningq1yq3ypneumococcaldepressiontamoxifenhormonetherapy5.7%breastcancer3%65y.o.diabetes≥ 126mg/dLmultidoseinitial series,then 1 doseat 2-6monthsovariancancercommunity-dwelling,postmenopausalwomen40-70 y.o.,ASCVD ≥10%, lowbleeding risk60y.o.overweight/ obesity75y.o.q5y40y.o.lungcancer52y.o.1 dose; 2doses (2-6monthsapart) ifimmunocompaspirindementia40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorq2yHepatitisB≥ 140mg/dL< 60y.o.GailmodelTyrer-CuzickmodelstatinTimedup andgo test≥ 200mg/dL40-59 y.o.,ASCVD ≥10%, lowbleeding risk6.5%q1ymammogramwomenage 55-64 y.o.≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsanxietyherpeszostercervicalcancerraloxifenecardiovasculardiseasearomataseinhibitors40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factorq1-2ymammogrambased on lifeexpectancy /health statusdyslipidemiaPREVENTequationq2y2 doses,2-6monthsapartHIVHepatitisCFractureRiskAssessmentToolcolorectalcancertobaccouse40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactors50y.o.q15y≥ 100mg/dLhypertension≥20%insufficientevidenceforscreeningq1yq3ypneumococcaldepressiontamoxifenhormonetherapy5.7%breastcancer3%65y.o.diabetes≥ 126mg/dLmultidoseinitial series,then 1 doseat 2-6monthsovariancancercommunity-dwelling,postmenopausalwomen40-70 y.o.,ASCVD ≥10%, lowbleeding risk60y.o.overweight/ obesity75y.o.q5y40y.o.lungcancer52y.o.1 dose; 2doses (2-6monthsapart) ifimmunocompaspirindementia40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorq2yHepatitisB

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
  1. ≥ 140 mg/dL
  2. < 60 y.o.
  3. Gail model
  4. Tyrer-Cuzick model
  5. statin
  6. Timed up and go test
  7. ≥ 200 mg/dL
  8. 40-59 y.o., ASCVD ≥ 10%, low bleeding risk
  9. ≥ 6.5%
  10. q1y mammogram
  11. women age 55-64 y.o.
  12. ≥ 40 y.o.; LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  13. anxiety
  14. herpes zoster
  15. cervical cancer
  16. raloxifene
  17. cardiovascular disease
  18. aromatase inhibitors
  19. 40-75 y.o., ASCVD ≥ 7.5%, ≥ 1 risk factor
  20. q1-2y mammogram based on life expectancy / health status
  21. dyslipidemia
  22. PREVENT equation
  23. ≤ q2y
  24. 2 doses, 2-6 months apart
  25. HIV
  26. Hepatitis C
  27. Fracture Risk Assessment Tool
  28. colorectal cancer
  29. tobacco use
  30. 40-75 y.o., LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  31. 50 y.o.
  32. q15y
  33. ≥ 100 mg/dL
  34. hypertension
  35. ≥20%
  36. insufficient evidence for screening
  37. q1y
  38. q3y
  39. pneumococcal
  40. depression
  41. tamoxifen
  42. hormone therapy
  43. ≥ 5.7%
  44. breast cancer
  45. 3%
  46. 65 y.o.
  47. diabetes
  48. ≥ 126 mg/dL
  49. multidose initial series, then 1 dose at 2-6 months
  50. ovarian cancer
  51. community-dwelling, postmenopausal women
  52. 40-70 y.o., ASCVD ≥ 10%, low bleeding risk
  53. 60 y.o.
  54. overweight / obesity
  55. 75 y.o.
  56. q5y
  57. 40 y.o.
  58. lung cancer
  59. 52 y.o.
  60. 1 dose; 2 doses (2-6 months apart) if immunocomp
  61. aspirin
  62. dementia
  63. 40-75 y.o.; LDL > 190 or ASCVD ≥ 10% + ≥ 1 risk factor
  64. q2y
  65. Hepatitis B